Clinical Trial Update: Evaluation of Lung Doppler Signals in Pulmonary Hypertension

View source ↗

Summary

The clinical trial evaluating lung Doppler signals as a biomarker for pulmonary hypertension was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Snippet

Sponsor: Echosense Ltd. | Conditions: Pulmonary Hypertension | Status: TERMINATED